Results 191 to 200 of about 4,341,243 (262)

Development of a behavioural modulation strategy for disease control based on network interventions. [PDF]

R Soc Open Sci
Zhang H, Sun Z, Zhao N, Liu Y, Liu S.
europepmc   +1 more source

Chameleon sequences reveal structural effects in proteins representing micelle‐like distribution of hydrophobicity

FEBS Open Bio, EarlyView.
Amino acids sequence of two different proteins with the same sequence (chameleon sequence—black boxes) represent in 3D structure of the proteins different secondary structures: HHHH—helical and BBB—Beta‐structural. The chains folded in water environment adopt different III‐order structures in which the chameleon fragments appear to adopt similar status
Irena Roterman, Katarzyna Stapor, Leszek Konieczny, Krzysztof Gądek, Piotr Nowakowski   +4 more
wiley   +1 more source

Scientometric analysis of neglected tropical disease research in Southeast Asia: insights for integrated disease control strategies. [PDF]

Trop Dis Travel Med Vaccines
Ogaya JB, Ong CJN, Ahmed MM, Solano RNM, Ramos JS, Othman ZK, Alhammadi OAS, Miranda AV, Okesanya OJ, Musa SS, Wardak MF, Xu L, Huang J, Kouwenhoven MBN, Lucero-Prisno Iii DE.   +14 more
europepmc   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

2023 Chinese national clinical practice guideline on diagnosis and management of ulcerative colitis

Chinese Medical Journal
Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association; Inflammatory Bowel Disease Quality Control Center of China, Yuanyuan Ji   +1 more
doaj   +1 more source

Prevention as a Pillar of Communicable Disease Control: Strategies for Equity, Surveillance, and One Health Integration. [PDF]

Epidemiologia (Basel)
Genovese G, Rizzo CE, Bartucciotto L, Calderone SM, Loddo F, Leonforte F, Mistretta A, Squeri R, Genovese C.   +8 more
europepmc   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

FEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake, Yuki Enoki, Yuka Nakazawa, Kazuaki Taguchi, Kazuaki Matsumoto   +4 more
wiley   +1 more source

2023 Chinese national clinical practice guideline on diagnosis and management of Crohn’s disease

Chinese Medical Journal
Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association; Inflammatory Bowel Disease Quality Control Center of China, Yuanyuan Ji   +1 more
doaj   +1 more source

FAO veterinary vaccine registration: enhancing access to safe and high-quality livestock vaccines for disease control programs and during emergency in countries. [PDF]

One Health Outlook
Cosseddu GM, Qiu Y, Goovaerts D, Metlin A, Blancato D, Maliski S, Tiensin T, Metwally S.   +7 more
europepmc   +1 more source